Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kenneth Allen Myszkowski Insider Profile
4 Followers
Kenneth Allen Myszkowski, CFO at Arrowhead Pharmaceuticals, holds 400.60K shares in Arrowhead Pharmaceuticals (Ticker: ARWR). Most recently, Kenneth Allen Myszkowski Sold $40,000 shares of Arrowhead Pharmaceuticals on Mar 08, 2024 for an estimated value of 1.41M.
Kenneth Allen Myszkowski Arrowhead Pharmaceuticals (ARWR)CFO
Arrowhead Pharmaceuticals (ARWR)
CFO
Ranked #3,799 out of 99,335 Corporate Insiders
Profitable Transactions
7 out of 7 Profitable Transactions
Average Return
+49.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Kenneth Allen Myszkowski's holdings
Insider Roles
CFO
Roles that Kenneth Allen Myszkowski holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jan 04, 2016 - Jan 04, 2017
Return:+71.70%
The most profitable trade made by Kenneth Allen Myszkowski
Kenneth Allen Myszkowski's Trading History
List of latest transactions for each holding click on a transaction to see Kenneth Allen Myszkowski's performance on stock
You May Also Like
Kenneth Allen Myszkowski insider profile FAQ
What is the percentage of profitable transactions made by Kenneth Allen Myszkowski?
The percentage of profitable transactions made by Kenneth Allen Myszkowski is 100%.
What is the average return per transaction made by Kenneth Allen Myszkowski?
The average return per transaction made by Kenneth Allen Myszkowski is 49.80%.
What stocks does Kenneth Allen Myszkowski hold?
Kenneth Allen Myszkowski holds: ARWR stocks.
What was Kenneth Allen Myszkowski’s latest transaction?
Kenneth Allen Myszkowski latest transaction was an Informative Sell of $1.41M.
What was Kenneth Allen Myszkowski's most profitable transaction?
Kenneth Allen Myszkowski’s most profitable transaction was an Informative Sell of ARWR stock on January 4, 2016. The return on the trade was 71.70%.
What is Kenneth Allen Myszkowski's role in Arrowhead Pharmaceuticals?
Kenneth Allen Myszkowski's role in Arrowhead Pharmaceuticals is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.